In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism
- 18 September 2000
- Vol. 38 (2) , 105-113
- https://doi.org/10.1002/1098-2396(200011)38:2<105::aid-syn1>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- 6-[18F]fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeysSynapse, 1998
- Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approachSynapse, 1998
- Density and Affinity of D1 and D2 Dopamine (DA) Receptors in Monkey: In Vivo PET studies with [11C]SCH23390 and [11C]RacloprideNeuroImage, 1998
- Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous InfusionJournal of Cerebral Blood Flow & Metabolism, 1997
- Distinct Binding Patterns of [3H]Raclopride and [3H]Spiperone at Dopamine D2Receptors in vivo in Rat Brain. Implications for Pet StudiesJournal of Receptors and Signal Transduction, 1997
- Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's DiseaseArchives of Neurology, 1995
- [ 11 C]raclopride and positron emission tomography in previously untreated patients with Parkinson's diseaseNeurology, 1994
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levelsSynapse, 1993
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomographyAnnals of Neurology, 1992
- Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primatesBrain Research, 1991